CROI 2021
HPTN researchers virtually presented 11 abstracts showcasing HPTN 052, HPTN 069, HPTN 071, HPTN 083, and the HPTN Modelling Center and HPTN Laboratory Center's ongoing work at the recent Conference on Retroviruses and Opportunistic Infections (CROI). HPTN 083 protocol chair Dr. Raphael J. Landovitz also delivered remarks during the CROI press conference regarding the study’s laboratory analysis findings of injectable cabotegravir for pre-exposure prophylaxis.
Presentations
Predictors of Pregnancy among HIV+ Women Enrolled in HPTN 052
Hair Mass Spectrometry Imaging of Daily Maraviroc Adherence In HPTN 069/ACTG 5305
Evaluation of a Rapid Test Algorithm to Estimate HIV Incidence: HPTN 071/PopART
HIV Drug Resistance in a Trial of Universal Testing & Treatment: HPTN 071/POPART
Impact of Early Viral Suppression on Incidence Assays: HPTN 071 (POPART)
Use of Multi-Assay Algorithms to Identify Recent HIV Infections: HPTN 071/POPART
Cost-effectiveness of Long-acting PrEP Among MSM/TGW in the U.S. (HPTN 083)
Laboratory Analysis of HIV Infections in HPTN 083: Injectable CAB For PrEP (HPTN 083)
Antibody Profiling Identifies Antibody Targets Associated with Natural HIV Control (Lab Center)
Comparison of Asante and Swift HIV Rapid Recency of Infection Assays (Lab Center)
Modelling the Impact Of COVID-19-Related Disruptions on HIV in the United States (Modelling Center)